ALGS Aligos Therapeutics, Inc.

Fundamentals / CIK 0001799448 / USD

Aligos Therapeutics, Inc. reported $5.83M in revenue and a net loss of $66.28M for the trailing twelve months ended September 30, 2026 (up 281.9% year over year), with a -1244.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALGS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$19.96M$9.98M$0-$123.2MFY 2019 Net Income: -$52.26M2019FY 2020 Revenue: $0FY 2020 Net Income: -$108.5M2020FY 2021 Revenue: $0FY 2021 Net Income: -$128.3M2021FY 2022 Revenue: $0FY 2022 Net Income: -$96.05M2022FY 2023 Revenue: $6.19MFY 2023 Net Income: -$87.68M2023FY 2024 Revenue: $3.61MFY 2024 Net Income: -$131.2M2024FY 2025 Revenue: $2.19MFY 2025 Net Income: -$24.19M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.19M $3.61M $6.19M $0 $0 $0 --
Research & Development $69.45M $70.27M $73.04M $85.08M $104.2M $79.89M $44.04M
Total Operating Expenses $90.17M $93.10M $103.7M $111.5M $132.7M $97.83M $54.04M
Operating Income -$87.98M -$89.15M -$88.13M -$97.58M -$128.3M -$97.83M -$54.04M
EBITDA -$87.06M -$88.13M -$86.57M -$95.27M -$125.3M -$95.10M -$52.65M
Income Before Tax -$23.88M -$130.9M -$86.88M -$95.94M -$128.2M -$108.4M -$52.18M
Income Tax Expense $314K $331K $795K $106K $143K $161K $85K
Net Income -$24.19M -$131.2M -$87.68M -$96.05M -$128.3M -$108.5M -$52.26M
Basic EPS -$2.45 -$20.94 -$34.20 -$56.25 -$80.50 -$271.75 -$651.00
Diluted EPS -$2.45 -$20.94 -$34.20 -$56.25 -$80.50 -$271.75 -$651.00
Basic Shares Outstanding 9.9M 6.3M 2.6M 1.7M 1.6M 399.5K 80.3K
Diluted Shares Outstanding 9.9M 6.3M 2.6M 1.7M 1.6M 399.5K 80.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $2.83M $0 $2.83M $169K $741K $965K $311K $606K
Research & Development $18.89M $24.05M $23.35M $17.04M $23.94M $13.98M $14.50M $16.03M
Total Operating Expenses $24.76M $29.67M $29.76M $21.98M $29.10M $19.53M $19.55M $21.19M
Operating Income -$21.89M -$1.89M -$26.93M -$21.81M -$28.36M -$18.57M -$19.24M -$20.56M
EBITDA -$21.59M -$1.59M -$26.58M -$21.56M -$28.16M -$18.27M -$19.05M -$20.32M
Income Before Tax -$21.53M $1.31M -$22.72M -$19.85M -$31.48M -$15.68M $43.13M -$82.12M
Income Tax Expense $326K $2.81M $317K $30K $56K $185K $43K $27K
Net Income -$21.86M -$1.50M -$23.04M -$19.88M -$31.54M -$15.86M $43.09M -$82.15M
Basic EPS -$2.09 -$0.14 -$2.21 -- -$3.04 -$1.53 $5.12 --
Diluted EPS -$2.09 -$0.14 -$2.21 -- -$3.04 -$1.53 -$2.11 --
Basic Shares Outstanding 10.5M 10.4M 10.4M -- 10.4M 10.4M 8.4M --
Diluted Shares Outstanding 10.5M 10.4M 10.4M -- 10.4M 10.4M 8.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.30M $37.00M $135.7M $81.35M $186.8M $220.4M $69.56M
Short-Term Investments $59.54M $19.94M -- $44.48M $3.92M $23.13M $48.10M
Cash & Short-Term Investments $77.80M $56.90M $135.7M $125.8M $205.8M $243.5M $117.7M
Other Current Assets $4.91M $5.09M $5.31M $7.60M $13.53M $5.94M $2.02M
Total Current Assets $82.86M $62.14M $141.1M $133.5M $204.4M $250.0M $120.2M
Property, Plant & Equipment, Net $1.87M $2.36M $3.26M $4.82M $6.18M $8.01M $8.52M
Long-Term Investments -- -- -- -- $15.11M -- $10.02M
Other Non-Current Assets $715K $627K $625K $634K $866K $377K $188K
Total Non-Current Assets $5.67M $7.95M $10.44M $13.15M $30.95M $15.29M $26.29M
Total Assets $88.53M $70.09M $151.5M $146.7M $235.4M $265.3M $146.5M
Accounts Payable $3.98M $2.57M $2.52M $4.74M $3.02M $3.31M $3.77M
Deferred Revenue (Current) $0 $151K $1.31M -- -- $7.89M --
Total Current Liabilities $21.23M $21.74M $23.91M $33.13M $38.96M $30.27M $13.82M
Deferred Revenue (Non-Current) -- -- -- -- -- $4.11M --
Other Non-Current Liabilities -- -- -- -- $133K $379K --
Total Non-Current Liabilities $13.76M $77.33M $35.54M $9.66M $11.68M $14.99M $15.51M
Total Liabilities $34.99M $99.07M $59.45M $42.79M $50.64M $45.26M $29.33M
Total Debt (incl. Leases) $5.25M $8.38M $11.14M $12.57M $14.46M $13.01M $14.33M
Common Stock $9.0K $8.0K $7.0K $4.0K $4.0K $4.0K $0
Retained Earnings -$642.2M -$618.0M -$486.8M -$399.1M -$303.1M -$174.7M -$66.20M
Accumulated Other Comp. Income $468K $451K $545K $401K $452K -$188K -$115K
Total Stockholders' Equity $53.55M -$28.97M $92.08M $103.9M $184.7M $220.0M -$64.89M
Total Equity $53.55M -$28.97M $92.08M $103.9M $184.7M $220.0M -$64.89M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $31.09M $30.38M $29.98M $18.30M $41.95M $18.66M $73.76M $37.00M
Short-Term Investments $0 $0 $24.93M $59.54M $57.15M $104.3M $64.10M $19.94M
Cash & Short-Term Investments $31.09M $30.38M $54.90M $77.80M $99.10M $122.9M $137.9M $56.90M
Accounts Receivable, Net -- $27.78M -- -- -- -- -- --
Other Current Assets $2.94M $3.93M $4.55M $4.91M $4.23M $4.89M $5.23M $5.09M
Total Current Assets $34.68M $62.13M $59.63M $82.86M $103.4M $127.9M $143.2M $62.14M
Property, Plant & Equipment, Net $1.21M $1.33M $1.59M $1.87M $2.04M $2.06M $2.21M $2.36M
Other Non-Current Assets $268K $759K $759K $715K $713K $640K $632K $627K
Total Non-Current Assets $12.51M $4.20M $4.93M $5.67M $6.33M $6.76M $7.49M $7.95M
Total Assets $47.19M $66.33M $64.56M $88.53M $109.8M $134.7M $150.7M $70.09M
Accounts Payable $3.21M $6.43M $7.64M $3.98M $4.65M $3.94M $4.46M $2.57M
Deferred Revenue (Current) -- -- -- $0 $168K $579K -- $151K
Total Current Liabilities $19.60M $28.34M $23.32M $21.23M $21.99M $20.27M $18.95M $21.74M
Total Non-Current Liabilities $16.28M $6.10M $9.45M $13.76M $15.94M $12.57M $15.31M $77.33M
Total Liabilities $35.88M $34.44M $32.77M $34.99M $37.93M $32.84M $34.25M $99.07M
Total Debt (incl. Leases) $11.90M $3.50M $4.35M $5.25M $6.07M $6.88M $7.87M $8.38M
Common Stock $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K $8.0K
Retained Earnings -$688.6M -$666.7M -$665.2M -$642.2M -$622.3M -$590.8M -$574.9M -$618.0M
Accumulated Other Comp. Income $437K $437K $438K $468K $455K $420K $447K $451K
Total Stockholders' Equity $11.31M $31.88M $31.79M $53.55M $71.83M $101.9M $116.4M -$28.97M
Total Equity $11.31M $31.88M $31.79M $53.55M $71.83M $101.9M $116.4M -$28.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$24.19M -$131.2M -$87.68M -$96.05M -$128.3M -$108.5M -$52.26M
Depreciation & Amortization $930K $1.03M $1.56M $2.31M $3.02M $2.73M $1.40M
Stock-Based Compensation $5.04M $8.45M $12.65M $14.69M $13.46M $2.98M $752K
Change in Payables $1.41M $54K -$2.22M $1.72M -$313K -$130K $385K
Operating Cash Flow -$82.50M -$80.74M -$79.00M -$79.39M -$115.7M -$74.26M -$46.77M
Capital Expenditure -- -$130K -$19K -$943K -$892K -$2.06M -$2.79M
Free Cash Flow -- -$80.87M -$79.02M -$80.33M -$116.6M -$76.33M -$49.55M
Investing Cash Flow -$37.83M -$18.28M $44.98M -$26.29M $3.02M $32.76M $6.79M
Common Stock Issued -- -- $23K -- -- -- --
Financing Cash Flow $101.6M $355K $88.33M $164K $78.68M $192.3M $85.53M
Net Change in Cash -$18.69M -$98.67M $54.31M -$105.5M -$33.96M $150.8M $45.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.86M -$1.50M -$23.04M -$19.88M -$31.54M -$15.86M $43.09M -$82.15M
Depreciation & Amortization $300K $300K $346K $257K $200K $300K $194K $241K
Stock-Based Compensation $1.28M $1.36M $1.31M $1.46M $1.47M $1.16M $959K $1.71M
Change in Payables -$3.22M -$1.21M $3.66M -$669K $752K -$402K $1.73M -$169K
Operating Cash Flow $1.45M -$24.95M -$23.13M -$21.75M -$24.34M -$15.50M -$20.91M -$18.40M
Investing Cash Flow -$127K $25.00M $34.93M -$2.02M $47.68M -$39.42M -$44.07M $19.97M
Financing Cash Flow -$8.0K $220K -$62K $123K -$53K -$177K $101.7M $97K
Net Change in Cash $1.32M $269K $11.74M -$23.64M $23.29M -$55.10M $36.77M $1.67M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -4024.9% -2469.0% -1423.5% -- -- -- --
Net Profit Margin -1106.7% -3633.6% -1416.2% -- -- -- --
Return on Equity (ROE) -45.2% -- -95.2% -92.4% -69.5% -49.3% --
Return on Assets (ROA) -27.3% -187.2% -57.9% -65.5% -54.5% -40.9% -35.7%
Current Ratio 3.90x 2.86x 5.90x 4.03x 5.25x 8.26x 8.70x
Quick Ratio 3.66x 2.62x 5.68x 3.80x 5.28x 8.04x 8.52x
Debt to Equity 0.10x -- 0.12x 0.12x 0.08x 0.06x --
Revenue Growth (YoY) -39.5% -41.7% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1244.2% -2112.1% -2033.4% -4024.9% -3306.7% -2506.5% -2675.1% -2469.0%
Net Profit Margin -1137.2% -2031.1% -1919.7% -1106.7% -3296.3% -2368.6% -1649.9% -3633.6%
Return on Equity (ROE) -586.3% -238.2% -284.1% -45.2% -120.4% -72.8% -45.7% --
Return on Assets (ROA) -140.5% -114.5% -139.9% -27.3% -78.8% -55.1% -35.3% -187.2%
Current Ratio 1.77x 2.19x 2.56x 3.90x 4.70x 6.31x 7.56x 2.86x
Quick Ratio 1.59x 2.05x 2.35x 3.66x 4.51x 6.06x 7.28x 2.62x
Debt to Equity 1.05x 0.11x 0.14x 0.10x 0.08x 0.07x 0.07x --
Revenue Growth (YoY) +281.9% -100.0% +810.0% -72.1% -40.7% -9.0% -55.2% -9.8%
Net Income Growth (YoY) -- -- -153.5% -- -- -413.4% -- --
EPS Growth (YoY) -- -- -143.2% -- -- -288.9% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001799448) · from September 30, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal